Windtree Therapeutics Stock Forward View - Simple Moving Average
| WINT Stock | USD 0.01 -0.01 -50.00% |
An accurate short-term forecast for Windtree Therapeutics depends on understanding not just its financials, but how the market's current narrative about Windtree Therapeutics compares to actual business performance.
In recent trading, Windtree Therapeutics shows the 14-period RSI at 28, aligning with traditional oversold thresholds. Values below 30 typically indicate extended downward momentum relative to recent price action.Momentum
Sell Stretched
Oversold | Overbought |
EPS Estimate Current Year -486.50 | Wall Street Target Price 4 | Quarterly Revenue Growth -1.00 |
This view connects Windtree Therapeutics headline attention with price response and peer context.
The Simple Moving Average forecasted value of Windtree Therapeutics on the next trading day is expected to be 0.01 with a mean absolute deviation of 0.0016 and the sum of the absolute errors of 0.1.Windtree Therapeutics after-hype prediction price | $ 0.01 |
Hype metrics are shown as one component among forecasting, technical, analyst, and earnings context.
Cross-verify projections for Windtree Therapeutics using Historical Fundamental Analysis of Windtree Therapeutics. The view provides historical context for the projection set.Windtree Therapeutics Additional Predictive Modules
Most predictive techniques to examine Windtree price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Windtree using various technical indicators. When you analyze Windtree charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Windtree Therapeutics Simple Moving Average Price Forecast For the 12th of March 2026
Given 90 days horizon, the Simple Moving Average forecasted value of Windtree Therapeutics on the next trading day is expected to be 0.01 with a mean absolute deviation of 0.0016 , mean absolute percentage error of 0.000015 , and the sum of the absolute errors of 0.1 .Please note that although there have been many attempts to predict Windtree Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Windtree Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Windtree Therapeutics Stock Forecast Pattern
| Backtest Windtree Therapeutics | Windtree Therapeutics Price Prediction | Research Analysis |
Windtree Therapeutics Forecasted Value
This next-day forecast for Windtree Therapeutics uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Windtree Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Windtree Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 103.3159 |
| Bias | Arithmetic mean of the errors | 0.0013 |
| MAD | Mean absolute deviation | 0.0016 |
| MAPE | Mean absolute percentage error | 0.0839 |
| SAE | Sum of the absolute errors | 0.095 |
Mean reversion opportunities in Windtree Therapeutics' arise when market prices disconnect from fundamental anchors such as earnings, book value, or historical price-to-earnings multiples.
Windtree Therapeutics After-Hype Price Density Analysis
Using probability distributions for Windtree Therapeutics forecasting acknowledges that no model can consistently predict Windtree Therapeutics' exact future price. The distribution approach quantifies model uncertainty and helps investors avoid overconfidence in any single forecast.
Next price density |
| Expected price to next headline |
Windtree Therapeutics Estimiated After-Hype Price Volatility
The after-hype price analysis for Windtree Therapeutics provides a news-conditional view of potential price outcomes. Windtree Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 16.97, respectively. This analysis complements technical and fundamental research by adding a news-sentiment dimension to Windtree Therapeutics' price forecasting.
Current Value
The after-hype framework applied to Windtree Therapeutics assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Windtree Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Windtree Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Windtree Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Windtree Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.56 | 16.96 | 0.00 | 3.59 | 3 Events | 5 Events | In 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.01 | 0.01 | 0.00 |
|
Windtree Therapeutics Hype Timeline
Windtree Therapeutics is at this time traded for 0.01. The company stock is not elastic to its hype. The average elasticity to hype of competition is -3.59. Windtree is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -1.56%. %. The volatility of related hype on Windtree Therapeutics is about 737.07%, with the expected price after the next announcement by competition of -3.58. The company has Price to Book (P/B) ratio of 0.56. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Windtree Therapeutics recorded earning per share (EPS) of 62.6. The company last dividend was issued on the 29th of April 2020. The firm completed a 1:50 stock split on 21st of February 2025. Given the investment horizon of 90 days the next estimated press release will be in 3 days. Cross-verify projections for Windtree Therapeutics using Historical Fundamental Analysis of Windtree Therapeutics. The view provides historical context for the projection set.Windtree Therapeutics Related Hype Analysis
The peer hype comparison table for Windtree Therapeutics includes downside risk metrics such as value-at-risk and maximum drawdown for Windtree Therapeutics' competitors. providing context for assessing the relative risk profile of a Windtree Therapeutics investment.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| REVB | Revelation Biosciences | 0.09 | 9 per month | 0.00 | -0.26 | 5.56 | -10.16 | 34.09 | |
| DRMA | Dermata Therapeutics | -0.06 | 8 per month | 0.00 | -0.03 | 16.48 | -16.23 | 80.83 | |
| ATXI | Avenue Therapeutics | -0.11 | 18 per month | 0.00 | -0.02 | 22.22 | -21.43 | 122.38 | |
| XRTX | XORTX Therapeutics | 0.00 | 0 per month | 0.00 | -0.07 | 7.02 | -5.77 | 25.64 | |
| VRAX | Virax Biolabs Group | -0.01 | 6 per month | 0.00 | -0.26 | 8.57 | -10.26 | 23.38 | |
| AIMD | Ainos Inc | 0.38 | 6 per month | 0.00 | -0.07 | 10.33 | -9.20 | 38.73 | |
| NKGN | NKGen Biotech Common | 0.00 | 0 per month | 9.61 | 0.17 | 35.14 | -10.00 | 298.33 | |
| NCEL | NewcelX | 0.00 | 0 per month | 0.00 | -0.02 | 10.00 | -10.70 | 34.00 | |
| GTBP | GT Biopharma | -0.02 | 9 per month | 0.00 | -0.06 | 8.33 | -10.64 | 37.01 | |
| ELAB | Elevai Labs Common | -23.28 | 6 per month | 0.00 | -0.43 | 8.62 | -23.72 | 53.38 |
Other Forecasting Options for Windtree Therapeutics
The movement of Windtree price is the central consideration for investors deciding whether to enter or hold a position. Noise in Windtree Stock price charts can make it difficult to distinguish meaningful trends from random fluctuations.Windtree Therapeutics Related Equities
The following equities are related to Windtree Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Windtree Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Windtree Therapeutics Market Strength Events
Investors use market strength indicators for Windtree Therapeutics to evaluate how the stock performs relative to broader market trends. These indicators support more precise timing of Windtree Therapeutics positions, helping investors maximize return and minimize poorly-timed trades.
| Rate Of Daily Change | 0.5 | |||
| Day Median Price | 0.01 | |||
| Day Typical Price | 0.01 | |||
| Price Action Indicator | -0.01 | |||
| Period Momentum Indicator | -0.01 | |||
| Relative Strength Index | 28.25 |
Windtree Therapeutics Risk Indicators
A careful analysis of Windtree Therapeutics' basic risk indicators helps investors understand the risk environment surrounding windtree stock. This understanding is an essential input for forecasting Windtree Therapeutics' future price and for deciding how to manage the associated investment risk.
| Mean Deviation | 5.7 | |||
| Standard Deviation | 16.52 | |||
| Variance | 272.75 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Windtree Therapeutics
Coverage intensity for Windtree Therapeutics matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Windtree Therapeutics Short Properties
Short sentiment tied to Windtree Therapeutics matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 52.6 K | |
| Cash And Short Term Investments | 1.8 M |
Additional Tools for Windtree Stock Analysis
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Directory Find actively traded commodities issued by global exchanges |